文献速递技术与安全介入CTPET

核医学中的辐射剂量:混合成像

Radiation dose in nuclear medicine: the hybrid imaging.
PubMed 文献 · Radiol Med · 2019-02-15

混合成像(SPECT/CT、PET/CT)因定位更准确而快速普及,但附加的CT部分增加了患者辐射暴露。有效剂量可由放射性药物活度乘以有效剂量系数、或CT剂量长度乘积乘以转换系数k估算,但不确定度高,仅作群体生物学风险的粗略估计,不能用于个体或流行病学研究。降低剂量的实用方法涵盖检查计划与执行阶段的调整。

要点

  • 混合成像附加的CT部分会额外增加患者辐射暴露。
  • 有效剂量不确定度高,仅为通用生物学风险估计,不能用于个体或流行病学研究。
  • 降低剂量需在计划与执行阶段调整:正当性判断、药物选择、诊断参考水平、水化排尿、新探测器/准直器与重建算法、CT方案与曝光参数。

核心结论

  • 混合成像因CT部分增加辐射暴露;有效剂量仅作通用风险估计,不能用于个体或流行病学;降低剂量需在计划与执行阶段采取多项措施。

研究设计与样本

  • 综述性文章,讨论SPECT/CT与PET/CT混合成像的辐射剂量估算方法与降低剂量的实用措施。

诊断标准与关键数值

  • 放射性药物有效剂量= administered activities × effective dose coefficients。
  • CT部分有效剂量= dose-length product × 转换系数k。
  • 有效剂量不确定度高,应解释为对生物学风险的宽泛、通用估计。

临床应用与阅片要点

  • 混合成像检查需对辐射暴露进行个体正当性判断。
  • 选择放射性药物时应考虑剂量。
  • 遵循诊断参考水平(DLR)。
  • 患者水化与膀胱排空有助于降低剂量。
  • 采用敏感探测器或准直器、新重建算法及合适的CT协议与曝光参数。

局限性

  • 有效剂量值存在高度不确定性。
  • 有效剂量不能应用于单个个体。
  • 有效剂量不应由于固有不确定性和过度简化而用于流行病学研究或人群风险估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Hybrid imaging procedures such as single-photon emission computed tomography/computed tomography (SPECT/CT) and positron emission tomography/computed tomography (PET/CT) showed a rapid diffusion in recent years because of their high sensitivity, specificity, and accuracy, due to a more accurate localization and definition of scintigraphic findings. However, hybrid systems inevitably lead to an increase in patient radiation exposure because of the added CT component. Effective doses due to the radiopharmaceuticals can be estimated by multiplying the administered activities by the effective dose coefficients, while for the CT component the dose-length product can be multiplied by a conversion coefficient k. However, the effective dose value is subject to a high degree of uncertainty and must be interpreted as a broad, generic estimate of biologic risk. Although the effective dose can be used to estimate and compare the risk of radiation exposure across multiple imaging techniques, clinicians should be aware that it represents a generic evaluation of the risk derived from a given procedure to a generic model of the human body. It cannot be applied to a single individual and should not be used for epidemiologic studies or the estimation of population risks due to the inherent uncertainties and oversimplifications involved. Practical ways to reduce radiation dose to patients eligible for hybrid imaging involve adjustments to both the planning phase and throughout the execution of the study. These methods include individual justification of radiation exposure, radiopharmaceutical choice, adherence to diagnostic reference levels (DLR), patient hydration and bladder voiding, adoption of new technical devices (sensitive detectors or collimators) with new reconstruction algorithms, and implementation of appropriate CT protocols and exposure parameters.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Salvatori M, Rizzo A, Rovera G, et al. Radiation dose in nuclear medicine: the hybrid imaging. Radiol Med. 2019. PMID: 30771217. doi:10.1007/s11547-019-00989-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。